Mad Hedge Technology Letter May 9, 2025 Fiat Lux Featured Trade: (THE FIGHT FOR AI SUPREMACY) (GOOGL), (AAPL)
Author Archives: april@madhedgefundtrader.com
We are getting to the part of the cycle where tech could potentially be cannibalizing each other. The fact is that the overall pie is not growing fast enough, and competition is. Search is a massive market, and participants are all vying for ad dollars. Once what was thought of as a duopoly is no […]
(AMERICAN TRADE POLICY HANDS AUSTRALIAN BEEF A TOP SLOT) May 9, 2025 Hello everyone The Fed left rates unchanged, as expected, citing inflation concerns and continued uncertainty across the economic landscape. Australia scores big thanks to Trump President Trump has just gifted Australia near monopoly status in China’s almost $5 billion […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Mad Hedge Biotech and Healthcare Letter May 8, 2025 Fiat Lux Featured Trade: (A DOUBLE HELIX OF OPPORTUNITY) (CRSP), (NTLA)
I never fully appreciated the potential of gene therapy until last fall when my college friend Eric called with surprising news. His 14-year-old daughter Sophie, who’d struggled with sickle cell disease her whole life, had undergone treatment with Casgevy, a CRISPR-based gene therapy developed by CRISPR Therapeutics (CRSP) and Vertex (VRTX). Six months later, she […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]